Well-Being, PsychologicalNCT06483568
Behavioral Mechanisms and Health Outcomes of Positive Psychological Intervention
A study testing Pathways to Happiness Intervention and Personal Organization Activities in people with Well-Being, Psychological, run by Rutgers, The State University of New Jersey.
Trial summary
The goal of this clinical trial is to learn if engaging in a multi-activity positive psychology intervention increases emotional well-being The main aims of this project are to: 1. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Well-Being, Psychological
- What is being tested?
- Pathways to Happiness Intervention and Personal Organization Activities
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 250 participants
- Where
- No sites listed yet
- Study dates
- 15 Jul 2024to 1 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Fluent or native English speaker capable of completing survey questionnaires in English
Who cannot join
- Major depressive disorder (PHQ-9 > or = 15)
About this study
The goal of this clinical trial is to learn if engaging in a multi-activity positive psychology intervention increases emotional well-being
The main aims of this project are to:
Read more
- Test the efficacy of a multi-activity positive psychology intervention for increasing emotional well-being in a racial-ethnically and socioeconomically diverse sample.
- Identify physical and social behavioral mechanisms driving positive psychology intervention effects on emotional well-being change and the durability of these effects over time.
- Examine physical health outcomes stemming from emotional well-being gains.
Participants will:
Visit the laboratory three times to complete survey measures and physical assessments.
Complete brief survey items three times a day for 10 weeks of the study period. Engage with assigned activities weekly for four weeks of the study period.
Read the detailed description
Participation will span 20 weeks around a four-week treatment phase. Assessments will involve three lab visits and experience sampling method surveys completed on participants' smart phones in response to short message service (SMS) message alerts.
Lab Visit 1 (Baseline): Participants will begin participation with an in-person lab visit held in small groups. This visit will begin with a guided informed consent procedure. Participants will complete baseline self-report measures and physiological assessments and receive procedure instructions.
Pre-Intervention Monitoring (weeks 1 \& 2): For two weeks, participants will compete three very brief experience sampling surveys per day.
Random Assignment, Treatment and Monitoring (weeks 3,4,5,\& 6): Participants will be randomly assigned to the online four-week Pathways to Happiness treatment condition or a matched activity control condition. All participants will complete the four weeks of activities (either Pathways to Happiness Positive Psychology Intervention (PPI) or control activities) on the Pathways to Happiness platform. They will complete weekly check-in items on the Pathways to Happiness platform to assess their compliance with the activity instructions and their experiences with the activities. Participants in both conditions will continue completing experience sampling surveys during this time.
Lab Visit 2 (Post-Test), after week 6: The second lab visit will occur after week six, following the treatment phase. It will involve identical questionnaires and physiological screenings as in the baseline visit.
Post-Intervention Monitoring (weeks 7\&8): After the treatment phase, two weeks of post-intervention experience sampling survey monitoring will begin.
Waiting Period: Participants will not engage in any formal study activities from weeks 9 to 19.
Follow-Up Monitoring (weeks 19-20): Follow-up experience sampling monitoring will commence for the final two weeks of the study, 10 weeks after the previous monitoring period.
Lab Visit 3 (Follow-Up), after week 20: The final lab visit, identical to the others, will occur after week 20 and will conclude with an exit interview regarding participants' experiences in the study and with each PPI activity.
- Conditions
- Well-Being, Psychological
- Being tested
- Pathways to Happiness Intervention, Personal Organization Activities
- Keywords
- Emotional Well-Being, Happiness, Gratitude, Kindness, Self-Compassion, Capitalization
- Medical subject headings
- Psychological Well-Being
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pathways to Happiness InterventionBehavioural
Four weeks of activities including a gratitude journal, random acts of kindness, self-compassionate letter, and capitalizing on positive events activities.
Personal Organization ActivitiesBehavioural
Four weeks of activities including a completed tasks journal, weekly "task burst," productivity letter, and talking to others about task activities.
| Study group | Role | What they receive |
|---|---|---|
| Positive Psychology Intervention Activities | Experimental | Four week intervention with four weekly activities including gratitude journal, random acts of kindness, self-compassionate letter, and capitalizing on positive events activities. Receives: Behavioral: Pathways to Happiness Intervention |
| Personal Organization Activities | Sham comparator | Control participants will complete procedure-matched activities related to personal organization, including writing in a completed tasks journal, completing a weekly task burst, productivity letter, and talking to others about tasks activities. Receives: Behavioral: Personal Organization Activities |
What is being measured
The primary outcome is the main question the study is designed to answer.
Life Satisfaction
Satisfaction with Life Scale, 1-7 scale, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Positive Affect
Scale of Positive and Negative Affect, 1-5 scale, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Negative Affect
Scale of Positive and Negative Affect, 1-5 scale, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Meaning in Life
Meaning in Life Questionnaire, 1-7 scale, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Optimism
Life Orientation Test-Revised, 1-5 scale, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Perceived General Health
Medical Outcomes Study (MOS) Short Form Health Survey (SF-36), General Health Perceptions Subscale, 1-5, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Blood Pressure
Systolic and Diastolic Blood Pressure In-lab measurement with OMRON 10 Series Wireless Upper Arm Blood Pressure Monitor
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Heart Rate
In-lab measurement with OMRON 10 Series Wireless Upper Arm Blood Pressure Monitor
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Peak Expiratory Flow Rate
In-lab measurement with EasyOne Air Spirometer
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Grip Strength
In-lab measurement with Jamar Plus+ Digital Hand Dynamometer
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Momentary Mood
Rate your current mood. 1 (very bad) to 7 (very good), higher scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary Meaning in Life
Daily Meaning Scale, 1-7, higher scores better
Measured: 3x daily; weeks 1-8, 19, 20
Secondary outcomes (42)
Amusement
Dispositional Positive Emotions Scale, 1-7, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Awe
Dispositional Positive Emotions Scale, 1-7, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Compassion
Dispositional Positive Emotions Scale, 1-7, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Contentment
Dispositional Positive Emotions Scale, 1-7, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Joy
Dispositional Positive Emotions Scale, 1-7, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Love
Dispositional Positive Emotions Scale, 1-7, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Pride
Dispositional Positive Emotions Scale, 1-7, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Hope
State Hope Scale, 1-8, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Depression
Patient Health Questionnaire-9, 0-27, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Anxiety
State-Trait Anxiety Inventory, 1-4, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Perceived Stress
Perceived Stress Scale, 0-4, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Loneliness
UCLA Loneliness Scale, 1-4, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Social Connectedness
Comprehensive Inventory of Thriving, 1-5, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Social Support
Perceived Social Support Scale, 1-5, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Sleep Quality
Pittsburgh Sleep Quality Index, 0-21, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Cigarette Use
cigarette smoking days/month x cigarettes per average smoking day, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Tobacco Use (non-cigarette products)
tobacco use days/month x average uses per day of using, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Alcohol Use
days in last month drinking x average number of drinks/drinking day, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Vigorous Activity Level
International Physical Activity Questionnaire, days/week x minutes/day, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Moderate Activity Level
International Physical Activity Questionnaire, days/week x minutes/day, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Walking
International Physical Activity Questionnaire, days/week x minutes/day, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Physical Functioning
MOS Short Form Health Survey (SF-36), Physical Functioning Subscale, 1-3, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Role Functioning--Physical
MOS Short Form Health Survey (SF-36), Physical Role Functioning Subscale, 0-4, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Role Functioning--Emotional
MOS Short Form Health Survey (SF-36), Emotional Role Functioning Subscale, 0-3, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Social Functioning
MOS Short Form Health Survey (SF-36), Social Functioning Subscale, 0-5, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Sitting
International Physical Activity Questionnaire, hours/weekday, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Bodily Pain
MOS Short Form Health Survey (SF-36), Pain Subscale, 2-11, lower scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
General Mental Health
MOS Short Form Health Survey (SF-36), General Mental Health Subscale, 1-6, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Vitality
MOS Short Form Health Survey (SF-36), Vitality Subscale, 1-6, higher scores better
Measured: baseline, immediate post-treatment, 14-week post-treatment follow-up
Momentary physical activity
Physical activity behaviors checklist, 0-3, higher scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary tobacco use
Have you used a tobacco product in the previous 4 hours? 0 (no)/1(yes), lower scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary alcohol use
Have you consumed alcohol in the previous 4 hours? 0 (no)/1(yes), lower scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary eating
Have you eaten [fruit or vegetable/sugary dessert, snack, or beverage] in the previous 4 hours? 0-2, higher scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary connective Behaviors
Connective behaviors checklist, 0-5, higher scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary Stress
How stressed do you feel right now? 1(not at all) to 7 (very much), lower scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary Depression
How depressed do you feel right now? 1(not at all) to 7 (very much), lower scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary Anxiety
How anxious do you feel right now? 1(not at all) to 7 (very much), lower scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary Loneliness
How lonely do you feel right now? 1(not at all) to 7 (very much), lower scores better
Measured: 3x daily; weeks 1-8, 19, 20
Momentary Perceived General Health
How do you feel in terms of your physical health right now? 1 (poor) to 5 (excellent), higher scores better
Measured: 3x daily; weeks 1-8, 19, 20
Sleep Quality
How would you rate the quality of your sleep last night? 1 (very bad) to 4 (very good), higher scores better
Measured: 1x daily; weeks 1-8, 19, 20
Sleep Duration
Wake up time - (lights out time + time to fall asleep), higher scores better
Measured: 1x daily; weeks 1-8, 19, 20
Common Symptoms Checklist
1-5, lower scores better
Measured: 1x daily; weeks 1-8, 19, 20
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jul 2024
- Study start15 Jul 2024 (estimated)
- Primary completion1 Jul 2025 (estimated)
- Study completion1 Jul 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Well-Being, PsychologicalStudies of the same condition, open and under way.
- More trials run by Rutgers, The State University of New JerseyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomly assigned to complete positive psychology intervention activities or procedure-matched activities related to personal organization.
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 250 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rutgers, The State University of New Jersey
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Samantha J. Heintzelman, PhD, Rutgers, The State University of New Jersey
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06483568
- Sponsor's protocol ID
- Pro2023002402
- Status last verified
- Jun 2024
- First submitted
- 26 Apr 2024
- Last updated
- 3 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data collected during the trial, after deidentification, and the study protocol materials will be shared on the Open Science Framework.
Study at a glance
From the registry record, last updated by the sponsor on 3 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Behavioral Mechanisms and Health Outcomes of Positive Psychological Intervention
- ClinicalTrials.gov ID
- NCT06483568
- Acronym / sponsor ID
- Pro2023002402
- Conditions
- Well-Being, Psychological
- Keywords
- Emotional Well-Being, Happiness, Gratitude, Kindness, Self-Compassion, Capitalization
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 250 participants (estimated)
- Lead sponsor
- Rutgers, The State University of New JerseyUniversity, hospital or other
- Study start
- 15 Jul 2024 (estimated)
- Primary completion
- 1 Jul 2025 (estimated)
- Study completion
- 1 Jul 2025 (estimated)
- First posted
- 3 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if engaging in a multi-activity positive psychology intervention increases emotional well-being
The main aims of this project are to:
- Test the efficacy of a multi-activity positive psychology intervention for increasing emotional well-being in a racial-ethnically and socioeconomically diverse sample.
- Identify physical and social behavioral mechanisms driving positive psychology intervention effects on emotional well-being change and the durability of these effects over time.
- Examine physical health outcomes stemming from emotional well-being gains.
Participants will:
Visit the laboratory three times to complete survey measures and physical assessments.
Complete brief survey items three times a day for 10 weeks of the study period. Engage with assigned activities weekly for four weeks of the study period.
Detailed description
Participation will span 20 weeks around a four-week treatment phase. Assessments will involve three lab visits and experience sampling method surveys completed on participants' smart phones in response to short message service (SMS) message alerts.
Lab Visit 1 (Baseline): Participants will begin participation with an in-person lab visit held in small groups. This visit will begin with a guided informed consent procedure. Participants will complete baseline self-report measures and physiological assessments and receive procedure instructions.
Pre-Intervention Monitoring (weeks 1 \& 2): For two weeks, participants will compete three very brief experience sampling surveys per day.
Random Assignment, Treatment and Monitoring (weeks 3,4,5,\& 6): Participants will be randomly assigned to the online four-week Pathways to Happiness treatment condition or a matched activity control condition. All participants will complete the four weeks of activities (either Pathways to Happiness Positive Psychology Intervention (PPI) or control activities) on the Pathways to Happiness platform. They will complete weekly check-in items on the Pathways to Happiness platform to assess their compliance with the activity instructions and their experiences with the activities. Participants in both conditions will continue completing experience sampling surveys during this time.
Lab Visit 2 (Post-Test), after week 6: The second lab visit will occur after week six, following the treatment phase. It will involve identical questionnaires and physiological screenings as in the baseline visit.
Post-Intervention Monitoring (weeks 7\&8): After the treatment phase, two weeks of post-intervention experience sampling survey monitoring will begin.
Waiting Period: Participants will not engage in any formal study activities from weeks 9 to 19.
Follow-Up Monitoring (weeks 19-20): Follow-up experience sampling monitoring will commence for the final two weeks of the study, 10 weeks after the previous monitoring period.
Lab Visit 3 (Follow-Up), after week 20: The final lab visit, identical to the others, will occur after week 20 and will conclude with an exit interview regarding participants' experiences in the study and with each PPI activity.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- Participants will be randomly assigned to complete positive psychology intervention activities or procedure-matched activities related to personal organization.
| Arm | Type | Receives |
|---|---|---|
| Positive Psychology Intervention Activities | Experimental | Behavioral: Pathways to Happiness InterventionFour week intervention with four weekly activities including gratitude journal, random acts of kindness, self-compassionate letter, and capitalizing on positive events activities. |
| Personal Organization Activities | Sham comparator | Behavioral: Personal Organization ActivitiesControl participants will complete procedure-matched activities related to personal organization, including writing in a completed tasks journal, completing a weekly task burst, productivity letter, and talking to others about tasks activities. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Fluent or native English speaker capable of completing survey questionnaires in English
Key exclusion criteria (1 listed)
- Major depressive disorder (PHQ-9 > or = 15)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pathways to Happiness InterventionFour weeks of activities including a gratitude journal, random acts of kindness, self-compassionate letter, and capitalizing on positive events activities. | Behavioural | Positive Psychology Intervention Activities |
| Personal Organization ActivitiesFour weeks of activities including a completed tasks journal, weekly "task burst," productivity letter, and talking to others about task activities. | Behavioural | Personal Organization Activities |
Primary outcome
Life Satisfaction
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Satisfaction with Life Scale, 1-7 scale, higher scores better
Positive Affect
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Scale of Positive and Negative Affect, 1-5 scale, higher scores better
Negative Affect
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Scale of Positive and Negative Affect, 1-5 scale, lower scores better
Meaning in Life
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Meaning in Life Questionnaire, 1-7 scale, higher scores better
Optimism
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Life Orientation Test-Revised, 1-5 scale, higher scores better
Perceived General Health
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Medical Outcomes Study (MOS) Short Form Health Survey (SF-36), General Health Perceptions Subscale, 1-5, higher scores better
Blood Pressure
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Systolic and Diastolic Blood Pressure In-lab measurement with OMRON 10 Series Wireless Upper Arm Blood Pressure Monitor
Heart Rate
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
In-lab measurement with OMRON 10 Series Wireless Upper Arm Blood Pressure Monitor
Peak Expiratory Flow Rate
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
In-lab measurement with EasyOne Air Spirometer
Grip Strength
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
In-lab measurement with Jamar Plus+ Digital Hand Dynamometer
Momentary Mood
Time frame: 3x daily; weeks 1-8, 19, 20
Rate your current mood. 1 (very bad) to 7 (very good), higher scores better
Momentary Meaning in Life
Time frame: 3x daily; weeks 1-8, 19, 20
Daily Meaning Scale, 1-7, higher scores better
42 secondary outcomes
Amusement
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Awe
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Compassion
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Contentment
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Joy
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Love
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Pride
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Hope
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Depression
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Anxiety
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Perceived Stress
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Loneliness
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Social Connectedness
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Social Support
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Sleep Quality
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Cigarette Use
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Tobacco Use (non-cigarette products)
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Alcohol Use
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Vigorous Activity Level
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Moderate Activity Level
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Walking
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Physical Functioning
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Role Functioning--Physical
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Role Functioning--Emotional
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Social Functioning
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Sitting
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Bodily Pain
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
General Mental Health
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Vitality
Time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up
Momentary physical activity
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary tobacco use
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary alcohol use
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary eating
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary connective Behaviors
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary Stress
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary Depression
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary Anxiety
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary Loneliness
Time frame: 3x daily; weeks 1-8, 19, 20
Momentary Perceived General Health
Time frame: 3x daily; weeks 1-8, 19, 20
Sleep Quality
Time frame: 1x daily; weeks 1-8, 19, 20
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jul 2024.
- Individual participant dataSharing planned: Yes. Individual participant data collected during the trial, after deidentification, and the study protocol materials will be shared on the Open Science Framework.
Related trials for Well-Being, Psychological
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Not yet recruiting
REM Enhancement Sleep Technology for Well-being, Emotion, and Life Lift
Healthy Adult Participants
Recruiting
Effects of Red Panax Ginseng Supplementation on Cognitive Performance and Emotional Well-Being in Young Healthy Adults
Mental Acuity
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Pathways to Happiness Intervention and Personal Organization Activities in people with Well-Being, Psychological, run by Rutgers, The State University of New Jersey.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Life Satisfaction (time frame: baseline, immediate post-treatment, 14-week post-treatment follow-up). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2024.